For the Inventor, By the Inventor

Enter assignee name

Xuanzhu Pharma Co., Ltd.

USPTO Granted Patents = 28

EPO Patents = 18

Forward Citations = 21

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Frank Wu (14 out of 17 patents)

Aichen Wang (5 out of 7 patents)

Chutian Shu (4 out of 5 patents)

4. Zhenhua Huang (4 out of 12 patents)

5. Jinyuan Wang (3 out of 5 patents)

6. Zhenhua Wang (3 out of 4 patents)

7. Yanyan Dong (3 out of 6 patents)

8. Bo Chen (2 out of 5 patents)

9. Yuzhen Feng (2 out of 3 patents)

10. Liang Sun (2 out of 3 patents)

11. Yongqian Wu (2 out of 2 patents)

12. Yan Zhang (2 out of 5 patents)

13. Hui Zhang (2 out of 9 patents)

14. Mikio Morita (1 out of 17 patents)

15. Tatsuya Yamagishi (1 out of 18 patents)

28 patents: Sort by Forward Citations

1. 11111234 - Salt of a quinazoline derivative-like tyrosine kinase inhibitor and crystal form thereof (2021-09-07),

2. 11020381 - Biaryloxy derivatives as TTX-S blockers (2021-06-01),

3. 10689359 - Crystals of quinazoline derivative and preparation method therefor (2020-06-23),

4. 10633364 - Crystals of quinazoline derivative and preparation method therefor (2020-04-28),

5. 10507209 - Quinazoline derivatives substituted by aniline, preparation method and use thereof (2019-12-17),

6. 10300058 - Tyrosine kinase inhibitor and uses thereof (2019-05-28),

7. 10011592 - Polycyclic inhibitor of anaplastic lymphoma kinase (2018-07-03),

8. 9956222 - Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof (2018-05-01),

9. 9949976 - Kinase inhibitor and use thereof (2018-04-24),

10. 9914688 - Optically pure benzyl-4-chlorophenyl-C-glucoside derivative (2018-03-13),

11. 9796701 - Kinase inhibitor and use thereof (2017-10-24),

12. 9730934 - Quinazoline derivatives substituted by aniline, preparation method and use thereof (2017-08-15),

13. 9586939 - Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof (2017-03-07),

14. 9562029 - C-glycoside derivatives (2017-02-07),

15. 9527876 - Prodrugs of bicyclic substituted pyrimidine type PDE-5 inhibitors (2016-12-27),

XUANZHU PHARMA CO., LTD. is a pharmaceutical company specializing in the development and production of innovative drugs. With a strong focus on research and development, XUANZHU PHARMA strives to bring cutting-edge medications to market for the treatment of various diseases. Our team of experienced scientists and healthcare professionals work diligently to ensure the safety and efficacy of our products. Visit our website to learn more about our company and the groundbreaking therapies we offer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

28 Patents

#2 in Jinan

#970 in China

#22,560 in the World

Xuanzhu Pharma Co., Ltd.

Forward Citations = 21

24 inventors:

Frank Wu (14 out of 17 patents)

Aichen Wang (5 out of 7 patents)

Chutian Shu (4 out of 5 patents)

4. Zhenhua Huang (4 out of 12 patents)

5. Jinyuan Wang (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…